Benedetta Stocchetti-Lombardi

Head And Neck Medical Oncology Department
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Mucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center.

Mucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center.

Journal: Cancers

Published: March 17, 2026

Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse.

Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Journal: Immuno-oncology technology

Published: January 22, 2026

Editorial: Multi-omics in head and neck cancer: unveiling immunological biomarkers for therapy.

Editorial: Multi-omics in head and neck cancer: unveiling immunological biomarkers for therapy.

Journal: Frontiers in oncology

Published: January 06, 2026

Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.

Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.

Journal: Journal of cancer research and clinical oncology

Published: April 13, 2025

The chemo-free approach for PDL1-positive platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma: Viable option or misguided myth?

The chemo-free approach for PDL1-positive platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma: Viable option or misguided myth?

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 21, 2025

Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy.

Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy.

Journal: The oncologist

Published: March 21, 2025

Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.

Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.

Journal: Vaccines

Published: April 27, 2024

COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.

COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.

Journal: Endocrine-related cancer

Published: February 23, 2023

Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.

Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.

Journal: International journal of cancer

Published: April 22, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026